Biogen (BIIB) PT Lowered to $355 at Leerink Partners on Reduced Aducanumab Probability of Success
Go back to Biogen (BIIB) PT Lowered to $355 at Leerink Partners on Reduced Aducanumab Probability of SuccessBIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 201.21 -0.78 (0.39%) | |||||
---|---|---|---|---|---|---|
Previous Close | $201.99 | 52 Week High | $333.65 | |||
Open | $201.21 | 52 Week Low | $223.02 | |||
Day High | $201.21 | P/E | 25.76 | |||
Day Low | $201.21 | EPS | $7.81 | |||
Volume | 16,291 |